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In search of a diagnostic tool for the early detection of cancer, many investi- 
gators have looked for differences in the plasma enzyme activity of the normal 
and  tumor-bearing  animal.  Although  alterations  in  plasma  enzyme activity 
have been reported with a  number of tumors these findings have not  always 
been consistent. However, with certain transplanted tumors, there appeared  to 
be a  close correlation between tumor growth and  the increase  in  the plasma 
activity of the  enzyme lactic dehydrogenase  (LDH)  (1--4).  Pertinent  to  this 
observation  was  the  report  by Riley  (5)  of  a  transmissible  lactic  dehydro- 
genase-elevating  agent  (LDH  agent)  which  was  found  in  the  plasma  and 
tissues of many tumor-beating mice. Injection of this agent into normal mice 
produced a 5- to 10-fold increase in the plasma LDH activity of these animals 
within  72  hours.  Although  there  was  no  evidence of tumor growth  or gross 
pathology  (except  slight  spleuomegaly)  in  the  recipients  (6),  the  increased 
plasma LDH activity persisted for months and  the LDH agent could be re- 
covered and transferred serially to normal mice. 
Initially, Riley studied 26 different types of mouse tumors and recovered a  trans- 
missible LDH agent from all of these tumors (5). Because  of this high recovery, the 
relationship  of  the  LDH agent to  the  tumor process  was of considerable  interest. 
Recently, however, studies from a  number of laboratories have shown that not all 
tumors contain  this agent  (7-11).  In addition,  Notkins et al.  (7)  showed  that  the 
Moloney leukemia agent could be separated from the LDH agent by passage through 
rats without losing its ability to produce leukemia. This and other evidence  suggested 
that the LDH agent was not integrally related to the tumor but was a contaminant 
which was being carried by many serially transplanted mouse tumors (7). 
Because of the wide distribution and enzyme elevating capacity of the LDH agent, 
it  was  decided  to  reinvestigate  the  relationship  between  tumor  growth  and  the 
increase  in plasma LDI-I activity, employing a  mouse tumor (SS-70429) which  was 
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free of the LDH agent. Similar experiments have also been reported by Riley (8). 
The studies from our laboratory (12, 13) showed  that: (a)  the plasma LDH activity 
of the infected tumor-bearing animal was not only many times higher than that of 
the uninfected tumor-bearing animal but was also several times greater than could 
be accounted for by simply adding the plasma LDH activity of the normal animal 
infected with the LDH agent to  that of the uninfected tumor-bearing animal. (b) 
The early rise in plasma LDH prior to the actual appearance of the tumor was shown 
not to be due to the tumor but was the result of infection with the LDH agent. (c) 
There was a gradual increase in the plasma LDH activity of the uninfected tumor- 
bearing animal which paralleled tumor growth,  but a  transmissible agent was not 
associated with this elevation. From these studies it became clear that much of the 
increased plasma LDH activity previously thought to have been the result of tumor 
growth was in fact the result of contamination of the tumor with the LDH agent. 
Since the LI)H agent produced a major and long lasting increase in plasma 
LDH  activity, it  was  pertinent to  determine whether  other  enzymes were 
equally elevated  or  whether  LDH  was  the  only enzyme influenced by this 
agent. In addition, we wished to study the plasma activity of these enzymes in 
the infected tumor-bearing  animal as compared to the uninfected tumor-bearing 
animal. The results of our experiments, reported below, show that other en- 
zymes in addition to LDH are elevated and that quantitative differences in 
plasma enzyme activity do exist between the infected and uninfected tumor- 
bearing animal. 
Materials and Methods 
Animals.--CAF-1 and C3H/HeN male mice 4 to 6 weeks old, bred at the National Insti- 
tutes of Health, Bethesda, were used throughout the experiments. 
Tumors.--Mammary carcinoma CsHBA and plasma cell tumor SS-70429 both of CsH 
origin were kindly supplied by Dr. Morris Barrett of the National Cancer Institute. 
LDH Agent.--The LDH agent was originally isolated from the plasma of a mouse which 
had received the Moloney leukemia agent. At approximately weekly intervals thereafter, the 
LDH agent was passed by intraperitoneal injection of 0.1 ml of a 10  -1 saline dilution of plasma 
from infected animals into 4 to 6 week old normal CAF-1 male mice. A plasma pool from the 
7th serial passage of the LDH agent, P-7, was used in the earlier experiments. The plasma from 
the 8th serial passage, P-8, was used to prepare a pellet of the LDH agent, which was re- 
suspended to original volume in Eagle's basal medium with 20 per cent veal infusion broth. 
The procedure described by Moloney to concentrate virus from plasma was employed to pre- 
pare the pellet (14). P-7 and P-8 were stored in individual  vacuum sealed vials at -55°C. 
.Plasma for Enzyme Determinations.--Blood was obtained by orbital bleeding as described 
by Riley (15). Heparinized mieropipettes were used to obtain 0.1 to 0.2 ml of blood from each 
mouse. The blood was centrifuged at approximately 1500 g for 15 minutes and the plasma 
was separated from the cells and kept at 4°C until assayed. Hemolyzed specimens were not 
used. 
Enzyme Determinations.--Laefie dehydrogenase (LDH) was assayed as described by Wrob- 
lewski and LaDue (16). One unit of activity is defined as the amount of enzyme which produces 
a decrease in the optical density of reduced nicotinamide-adenine dinueleotide (NADH~) at 
340 m/~ of 0.001 per  1 minute. Malic dehydrogenase (MDH) was assayed as described by 
Mehler (17). One unit of activity is defined as the amount of enzyme which produces a decrease 
in the optical density of NADH2 at 340 m/a of 0.001 per 1 minute. Isocitrie dehydrogenase A. L. NOTKINS,  R. E. GREENFIELD~  D. MARSHALL~  L. BANE  187 
(ICDH) was assayed according to the method of Ochoa (18). The change in optical density 
resulting from the reduction of nicofinamide-adenine dinucleotide phosphate  (NADP)  was 
measured at 340 m#. One unit of activity is defined as the amount of enzyme which produces 
an increase in optical density of 0.001 per 1 minute. Aldolase was assayed by the method of 
Sibley and Lehninger (t9) as modified by Beck (20), except that the chromogen development 
reaction was shortened to 30 minutes. One unit of aldolase activity is defined as the amount 
of enzyme which will form  1 #x¢ of triose phosphate  from fructose-l,6-diphosphate  in  15 
minutes at 37°C. Assays were done on a Beckman DU spectrophotometer. Glutamic-oxalacetic 
transaminase (GOT) was assayed by the method of Steinberg, Baldwin, and Ostrow (21), One 
unit of activity is defined as the amount of enzyme which produces a decrease in the optical 
density of NADHs at 340 m# of 0.001 per 1 minute at 25°C. Phosphohexose isomerase (PHI) 
was assayed according to the procedure described by Bodansky (22). The data is expressed in 
Bodansky units. Alkaline phosphatase was assayed as described by Garen and Levinthal (23). 
The  increase  in optical density  resulting  from  the  dephosphorylation  of  p-nitrophenyl 
phosphate  was  followed  spectrophotometrically.  One  unit  of  activity  is  defined  as  the 
amount of enzyme which produces an increase in optical density at 410 m/~ of 0.001 per minute. 
All data were expressed as units of enzyme per mi of plasma. All assays were done on the 
Bausch & Lomb spectronic 505 except where noted. 
PROCEDURES 
CAF-1 male mice, 6 weeks old, were placed 4 per cage in 8 cages. On day zero, the 4 animals 
in each cage were bled and the plasma was pooled. Eight specimens were thus obtained. This 
pooling procedure was followed throughout  the experiments.  Several hours after obtaining 
these control specimens, one-half of the animals (cages 1 to 4) received 0.1 mi intraperitonealiy 
(ip) of a 10  "-2 dilution of the LDH agent in 0.85 per cent NaCI and were labeled experimental 
animals. The remaining animals (cages 5 to 8) received 0.1 ml of 0.85 per cent NaCI ip and 
were labeled control animals. On days 3, 7, 14, and 21 the mice were bled and a plasma pool 
was obtained from each cage. Each pool was assayed for malic dehydrogenase, phosphohexose 
isomerase, and isodtric dehydrogenase. A second group of animals was set up  in exactly the 
same way but the plasma pools from these animals were used to assay lactic dehydrogenase, 
glutamic-oxalacetic transaminase, alkaline phosphatase, and aldo]ase.  The enzyme activity of 
the control and experimental pools were determined, averaged, and the per cent increase was 
calculated. 
In the second experiment CsH/HeN male mice 5 weeks old  were divided  into  6 groups of 
24  animals each.  On day 0,  groups I  and 2 received  0.I ml of  0.85  per cent  NaCl ip.  Groups  3 
and 4 received  0.025 ml of  a 50 per cent  SS-70429 tumor suspension  in  0.85  per cent  NaCl. 
This  material  was  injected  subcutaneously  into  the  right  flank.  Groups 5 and 6 received  0.025 
mi of a 50 per cent CsI-IBA mammary tumor suspension  in 0.85  per cent  NaCl also  sub- 
cutaneously  in  the  right  flank.  Several  hours  after  implantation  of  the  tumors,  groups  2,  4,  and 
6 were inoculated intraperitoneally with 0.1 ml of a 10  ..2 dilution of the LDH agent (P-8).  On 
days 3, 4, 10, 11, 17, and 18 each animal was bled and four plasma pools were obtained from 
each group of 24 mice. Pools collected on days 3,  10, and  17 were used to assay lactic de- 
hydrogenase, malic dehydrogenase, and isocitric dchydrogenase. The pools collected on days 
4,  11, and  18 were used to assay aldolase. The arithmatic average of each group in the ap- 
propriate enzyme unit is reported. 
RESULTS 
Infection  of Normal  Mice with the LDH Agent.--Within  72  hours  after  in- 
jection of the LDH  agent, there was an increase in the plasma enzyme activity 
of five out of the seven enzymes studied  (Fig.  1).  GOT,  PHI,  MDH,  ICDH, 188  MULTIPLE  ENZYME  CHANGES 
and LDH were elevated from 50 to 800 per cent over the normal controls which 
were assayed at the  same time.  The increase in the plasma activity of these 
enzymes persisted for the 21 days of the experiment. Infection of normal mice 
with the LDH agent produced a 500 to 800 per cent increase in LDH activity, 
a 400 to 700 per cent increase in ICDH activity, a  100 to 150 per cent increase 
in MDH and PHI activity, and about a 50 per cent increase in GOT activity. 
Two enzymes, alkaline phosphatase and aldolase, remained within the normal 
range. MDH, LDH, and ICDH assays performed on a group of animals which 
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FIo. 1. Per cent increase in the activity of plasma enzymes of normal mice infected with the 
LDH agent. 
had  been infected  with  the  LDH agent  7  months  earlier showed  that  these 
enzymes were still elevated although to a  slightly lesser extent than that seen 
in newly infected animals. 
Infection of Tumor-Bearing Mice with the LDH A gent.--In the second experi- 
ment tumor-bearing animals with and without the LDH agent were followed 
for changes in plasma enzyme activity. On day 17 as seen in Fig. 2, the plasma 
LDH of infected mice bearing the  SS-70429  tumor was increased  7-fold over 
that of animals with the same tumor but uninfected, while the plasma LDH of 
infected  animals bearing mammary carcinoma  C3HBA was  2.5  times higher 
than its uninfected counterpart. As seen in Fig. 3, the plasma ICDH activity 
of animals with the SS-70429 tumor reached 8 times the level of its uninfected Units/ml Plosmo 
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FIo. 2. A comparison of plasma lactic dehydrogenase activity in normal and tumor-bearing 
mice experimentally infected with the LDH agent. The bars within each group (left to right) 
correspond to days 3, 10, and 17. 
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I~G. 3. A comparison  of plasma isocitric dehydrogenase  activity in normal and tumor° 
bearing mice experimentally  infected with the LDH agent. The bars within each group (left to 
right) correspond to days 3, 10, and 17. 
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FIG. 5. A comparison of plasma aldolase activity in normal and tumor-bearing mice experi- 
mentally infected with the LDH agent. The bars within each group (left to right) correspond 
to days 4, 11, and 18. 
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counterpart. Plasma ICDH of infected animals bearing  mammary carcinoma 
C~I-IBA was 7 times above that of the uninfected tumor-bearing animal on day 
10, but only 3 times higher on day 17. Plasma MDH, Fig. 4, from infected 
animals bearing  SS-70429 reached  4 times the level of its uninfected counter- 
part. On days 3 and 10 the plasma MDH activity of the infected mice with 
mammary carcinoma CJ-IBA was close to 3 times above its uninfected counter- 
part. However,  on day 17, the plasma MDH activity of the infected and un- 
infected mammary tumor-bearing animal was  about the same.  The plasma 
aldolase  activity, Fig.  5, of infected animals bearing either mammary carci- 
noma CaHBA or plasma cell tumor SS-70429 did not differ greatly from that 
of its uninfected counterpart. However,  this was not completely unexpected 
since the LDH agent did not produce an increase in the plasma aldolase ac- 
tivity of  the  normal  animal. 
Enzyme determinations on plasma from the uninfected tumor-bearing mice 
showed  that none of the four enzymes studied  (LDH, MDH,  ICDH,  and 
aldolase) were elevated on day 3. However,  with the exception of ICDH from 
animals bearing the SS-70429 tumor, all of these enzymes were elevated by day 
17.  Transfer of plasma (0.1 ml ip of a  10  -I dilution) from these  uninfected 
tumor-bearing animals to normal mice failed  to produce an increase  in the 
plasma enzyme activity of the recipients. 
DISCUSSION 
Riley has shown that infection of mice with the LDH agent produced a 5- 
to 10-fold increase in plasma LDH activity within 72 hours  (5). The experi- 
ments reported above showed that, in addition to LDH, four other enzymes 
were elevated. The per cent increase  in enzyme activity differed with each 
enzyme but was relatively constant for that enzyme over the 21 days of the 
experiment.  Further studies showed that LDH, ICDH, and MDH were still 
elevated at 7 months but at a slightly lower level. 
The mechanism by which the LDH agent produces  the increase in plasma 
enzyme activity remains obscure.  The  two most attractive hypotheses are 
that the LDH agent (a) stimulates cellular enzyme production or (b) produces 
cell damage and subsequent release of enzymes into the circulation.  Since the 
enzymes that were studied are found in most cells of the body, an agent or 
process which destroys or damages cells could produce an increase in plasma 
enzyme activity. Such an increase  could also result from destruction of cells 
concerned with the clearance or catabolism of enzymes. However,  the animals 
infected with the LDH agent showed no gross pathology, except slight spleno- 
megaly (6, 24), and apart from the elevation of plasma enzymes could not be 
distinguished from the uninfected animals.  Although gross pathology has not 
been reported, subtle changes in cell wall permeability could exist and permit 
enzyme leakage. The alternative to the cell damage hypothesis is that the LDH 192  MULTIPLE  ENZYME  CHANGES 
agent acts on a genetic or metabolic level so as to stimulate enzyme production 
and subsequent release into the circulation.  Increase in enzyme activity fol- 
lowing virus infection has been reported in a number of situations including 
mouse  fibroblasts  in tissue  culture infected with vaccinia (25), embryonate 
eggs infected with influenza  virus (26),  rabbit epithelium infected with the 
Shope papilloma virus (27), and bacteria infected with phage (28-30). 
At the present over 40 types of transplanted mouse tumors have been re- 
ported to carry a transmissible LDH-elevating agent (5, 7-11). The widespread 
distribution of this agent makes it particularly important in the study and 
evaluation of enzyme changes  in  the  tumor-bearing animal.  In  the  above 
experiment,  the plasma from uninfected and infected tumor-bearing animals 
were compared,  and it was shown that the early increase  in plasma enzyme 
activity (MDH, ICDH, LDH) was not due to the tumor but the LDH agent. 
However, by days 10 and 17 the uninfected tumor-bearing animals also began 
to show an increase in the plasma activity of these enzymes which paralleled 
the gross increase  in tumor size. Transfer of plasma from these  animals to 
normal  recipients  failed to  reveal  a  transmissible  enzyme elevating agent, 
thereby suggesting  that  the  increase  in plasma MDH,  LDH,  ICDH,  and 
aldolase of the uninfected tumor-bearing animals was related to the growing 
tumor and was independent of the LDH agent. 
As in previous experiments  (12) the increase in plasma LDH activity of the 
infected tumor-bearing (SS-70429) animal was several times greater than that 
which could be explained  by simply adding the plasma LDH activity of the 
uninfected tumor-bearing animal to that of the infected non-tumor-bearing 
animal. The experiments  reported above demonstrate a similar,  although less 
pronounced, increase in the plasma MDH activity of the infected tumor-bearing 
(SS-70429) animal. On the other hand, a more than additive increase in plasma 
enzyme activity was not seen with aldolase or substantiated with ICDH. In 
addition, animals with mammary carcinoma  C~-IBA and infected with the 
LDH agent failed to show a more than additive increase with any of the four 
enzymes studied (LDH, MDH, ICDH, and aldolase). 
In  those  infected tumor-bearing  animals  showing  a  more  than  additive 
increase in plasma enzyme activity, the tumor would appear to be the most 
likely source for these enzymes by providing additional cells (targets) upon 
which the LDH agent could act. However, many secondary changes are known 
to take place  in an animal during tumor growth. The tumor may stimulate 
the production of certain non-tumor cells such as those  of the reticuloendo- 
thelial system or immature blood cells (due to anemia), some of which may serve 
as target cells for the LDH agent. An increase  in the number of these cells 
following tumor implantation, and not the tumor, may therefore be responsible 
for the more than additive increase in the plasma enzyme activity of the in- 
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indirectly provided additional target cells, infection of that animal with the 
LDH agent would result  in  a  greater increase  in plasma  enzyme activity 
(LDH and MDH) than would be expected  by adding the plasma activity of 
the uninfected tumor-bearing animal to that of the infected non-tumor-bearing 
animal. The lack of such an increase in plasma ICDH and aldolase may be due 
to a relatively low concentration of these enzymes in the target cells as com- 
pared to MDH and LDH. Furthermore, a tumor which did not provide addi- 
tional target cells (the localized CaI-IBA may be such  a  tumor) would not be 
expected to produce a more than additive increase  in plasma enzyme activity 
when infected with the LDH agent.  In addition to enzyme production and 
release, differences in the solubility and  the rate of clearance  of an enzyme 
from the circulation  may be responsible for some of the observed plasma en- 
zyme differences. 
From the above experiments it can be seen that an unsuspected contaminant, 
carried  by as many as 40 different types of  mouse  tumors, may have been 
responsible for much of the increased plasma enzyme activity seen in tumor- 
bearing mice and previously attributed to the tumor. In addition, Riley believes 
that this agent may also have some influence on the metabolism of the tumor 
(31, 32).  Furthermore, Ransher and Notkins (33)  and  Rowe  (34) have evi- 
dence that the LDH agent interferes with infection by other viruses and Yaffe 
(10) has succeeded in propagating the LDH agent in tissue culture. At pres- 
ent, this agent has been isolated only from mice but further studies on its host 
range are warranted. 
SU'M~AR¥ 
Within 72 hours after injection of the LDH agent into  normal mice, five 
(LDH,  ICDH,  MDH,  PHI,  and  GOT)  out of the  seven  plasma  enzymes 
studied were elevated. This elevation persisted  for the duration of the experi- 
ment. Alkaline phosphatase and aldolase were not elevated. 
Plasma  from mice bearing  tumor SS-70429 and  infected with  the LDH 
agent showed 7 times more LDH, 8 times more ICDH, and 4 times more MDH 
activity than the plasma from mice with the same tumor but uninfected. The 
plasma aldolase activity from the infected tumor-bearing animal was approxi- 
mately the same as that from the uninfected tumor-bearing animal. Somewhat 
similar results, but lower in magnitude, were found with mice bearing mammary 
carcinoma Cg-IBA. 
The early rise in plasma enzyme activity (LDH, MDH, ICDH) prior to the 
actual appearance  of the tumor was shown to be due not to the tumor, but to 
the LDH agent.  Uninfected tumor-bearing mice  showed  a  late  increase  in 
plasma enzyme activity which appeared to be related to tumor growth. 
The  findings  reported  above  suggest  that  contamination with  the LDH 194  MULTIPLE  ENZY3KE CHANGES 
agent may have been responsible for much of the increased  plasma  enzyme 
activity previously attributed to the tumor. 
The authors wish to thank Dr. Henry Scherp for his invaluable advice and support during 
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